141 related articles for article (PubMed ID: 10499236)
1. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
[TBL] [Abstract][Full Text] [Related]
2. Disposition and tolerance of suxibuzone in horses.
Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
[TBL] [Abstract][Full Text] [Related]
3. The disposition of suxibuzone in the horse.
Delbeke FT; Vynckier L; Debackere M
J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
[TBL] [Abstract][Full Text] [Related]
4. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
Mills PC; Ng JC; Auer DE
J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
[TBL] [Abstract][Full Text] [Related]
5. Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration.
Mills PC; Ng JC; Skelton KV; Seawright AA; Auer DE
Aust Vet J; 1995 Aug; 72(8):304-8. PubMed ID: 8579562
[TBL] [Abstract][Full Text] [Related]
6. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
Landuyt J; Delbeke FT; Debackere M
J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
Arifah AK; Lees P
J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
[TBL] [Abstract][Full Text] [Related]
9. Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses.
Sabaté D; Homedes J; Salichs M; Sust M; Monreal L
Equine Vet J; 2009 Sep; 41(7):700-5. PubMed ID: 19927590
[TBL] [Abstract][Full Text] [Related]
10. [The concentration changes of different phenylbutazone formulations in horse plasma].
Keller H; Hashem A
Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
[TBL] [Abstract][Full Text] [Related]
11. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH
Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176
[TBL] [Abstract][Full Text] [Related]
12. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
Cheng Z; McKeller Q; Nolan A
J Vet Pharmacol Ther; 1998 Aug; 21(4):315-21. PubMed ID: 9731955
[TBL] [Abstract][Full Text] [Related]
14. Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses.
Monreal L; Sabaté D; Segura D; Mayós I; Homedes J
Res Vet Sci; 2004 Apr; 76(2):145-9. PubMed ID: 14672858
[TBL] [Abstract][Full Text] [Related]
15. Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.
Andrews FM; Reinemeyer CR; Longhofer SL
Vet Ther; 2009; 10(3):113-20. PubMed ID: 20037965
[TBL] [Abstract][Full Text] [Related]
16. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetics of phenylbutazone in healthy young-adult and geriatric horses.
Zaghloul IY; Bedenice D; Ceresia ML; Jones PH; Sanchez-Londono A; Lobo MN; Böhlke M; Paradis MR
Am J Vet Res; 2024 Jun; ():1-8. PubMed ID: 38942059
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
Caturla MC; Cusido E
J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of methocarbamol and phenylbutazone in exercised Thoroughbred horses.
Knych HK; Stanley SD; Seminoff KN; McKemie DS; Kass PH
J Vet Pharmacol Ther; 2016 Oct; 39(5):469-77. PubMed ID: 26924025
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and anti-inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses.
Knych HK; Arthur RM; McKemie DS; Baden RW; Seminoff K; Kass PH
Equine Vet J; 2021 Jan; 53(1):102-116. PubMed ID: 32145701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
